UTHR UNITED THERAPEUTICS CORP DEL

Ownership history in Edgestream Partners, L.P.  ·  10 quarters on record

This page tracks every 13F SEC filing in which Edgestream Partners, L.P. reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.19% (2023 Q3)
Avg. % of fund
0.08%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,234 -4,883 -68.6% 0.03% $937K $419.21
2024 Q4 ADDED 7,117 +2,696 +61.0% 0.11% $2.5M $352.84
2024 Q3 ADDED 4,421 +1,863 +72.8% 0.07% $1.6M $358.35
2024 Q1 REDUCED 2,558 -2,614 -50.5% 0.03% $588K $229.72
2023 Q4 REDUCED 5,172 -5,259 -50.4% 0.08% $1.1M $219.89
2023 Q3 ADDED 10,431 +6,370 +156.9% 0.19% $2.4M $225.87
2023 Q2 ADDED 4,061 +241 +6.3% 0.08% $896K $220.75
2022 Q2 REDUCED 3,820 -970 -20.3% 0.07% $900K $235.64
2021 Q3 REDUCED 4,790 -5,141 -51.8% 0.05% $884K $184.58
2021 Q2 INITIATED 9,931 0.11% $1.8M $179.41
% of Fund (quarterly)    UTHR price (monthly, adj. close)
← Back to Edgestream Partners, L.P. Holdings